Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Ethaneperoxoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethaneperoxoic Acid SCHEMBL809506 | 1.00 | ALDH1A1 (0.47) | — | |
| Ethaneperoxoic Acid SCHEMBL1451487 | 1.00 | ALDH1A1 (0.47) | — | |
| Ethaneperoxoic Acid SCHEMBL1501690 | 0.96 | ALDH1A1 (0.50) | — | |
| Ethaneperoxoic Acid SCHEMBL1501687 | 0.96 | — | — | |
| Ethaneperoxoic Acid SCHEMBL11541678 | 0.92 | FFAR3 (0.58) | — | |
| Ethaneperoxoic Acid SCHEMBL912961 | 0.92 | — | — | |
| Ethaneperoxoic Acid SCHEMBL7069654 | 0.92 | FFAR3 (0.58) | — | |
| Ethaneperoxoic Acid SCHEMBL8145807 | 0.92 | FFAR3 (0.58) | — | |
| Ethaneperoxoic Acid SCHEMBL4954376 | 0.91 | TSHR (0.55) | — | |
| Ethaneperoxoic Acid SCHEMBL562267 | 0.91 | TSHR (0.55) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0823913-B1 | SYNTHESIS OF THE BREAST TUMOR-ASSOCIATED ANTIGEN DEFINED BY MONOCLONAL ANTIBODY MBR1 AND USES THEREOF | SLOAN KETTERING INST CANCER (US) | 2006-01-11 | — | — | EP | disclosed |
| EP-0854878-A4 | SYNTHESIS OF GLYCOCONJUGATES OF THE LEWIS Y EPITOPE AND USES THEREOF | SLOAN KETTERING INST CANCER (US) | 2004-03-24 | — | — | EP | disclosed |
| US-6645935-B2 | De-silylating, to form an N-sulfonamide pentasaccharide; cleaving N-sulfonamide cleaving the N-sulfonamide pentasaccharide formed in to form a deprotected pentasaccharide; acetylating deprotected pentasaccharide | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 2003-11-11 | — | — | US | disclosed |
| US-6544952-B1 | Useful as vaccines for inducing antibodies to epithelial cancer cells | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 2003-04-08 | — | — | US | disclosed |
| US-20020038017-A1 | Synthesis of glycoconjugates of the lewis y epitope and uses thereof | THE TRUSTEES OF COLUMBIA UNIVERSITY | 2002-03-28 | — | — | US | disclosed |
| US-6303120-B1 | INDUCING ANTIBODIES IN A SUBJECT TO AN ALLYL-SUBSTITUTED PENTASACCHARIDE BY ADMINISTERING THE COMPOUND CONJUGATED TO A PROTEIN CARRIER AT ITS ALLYL GROUP. | MEMORIAL SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 2001-10-16 | — | — | US | disclosed |
| US-6090789-A | OLIGOSACCHARIDES USEFUL AS A VACCINE FOR INDUCING ANTIBODIES TO HUMAN BREAST CANCER CELLS IN AN ADJUVANT THERAPY | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2000-07-18 | — | — | US | disclosed |
| EP-0823913-A4 | SYNTHESIS OF THE BREAST TUMOR-ASSOCIATED ANTIGEN DEFINED BY MONOCLONAL ANTIBODY MBR1 AND USES THEREOF | SLOAN KETTERING INST CANCER (US) | 1998-11-04 | — | — | EP | disclosed |
| EP-0854878-A1 | SYNTHESIS OF GLYCOCONJUGATES OF THE LEWIS Y EPITOPE AND USES THEREOF | Sloan-Kettering Institute For Cancer Research (US) | 1998-07-29 | — | — | EP | disclosed |
| EP-0823913-A1 | SYNTHESIS OF THE BREAST TUMOR-ASSOCIATED ANTIGEN DEFINED BY MONOCLONAL ANTIBODY MBR1 AND USES THEREOF | Sloan-Kettering Institute For Cancer Research (US) | 1998-02-18 | — | — | EP | disclosed |
| US-5708163-A | Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof | SLOAN-KETTERING INSTITUTE OF CANCER RESEARCH (US) | 1998-01-13 | — | — | US | disclosed |
| US-5679769-A | SOLID PHASE SYNTHESIS OF OLIGOSACCHARIDES-OLIGOPEPTIDES; ANTICARCINOGENIC AGENTS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1997-10-21 | — | — | US | disclosed |
| WO-1997003995-A1 | SYNTHESIS OF GLYCOCONJUGATES OF THE LEWIS Y EPITOPE AND USES THEREOF | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1997-02-06 | — | — | WO | disclosed |
| WO-1996040198-A1 | SYNTHESIS OF ASPARAGINE-LINKED GLYCOPEPTIDES ON A POLYMERIC SOLID SUPPORT | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996034005-A1 | SYNTHESIS OF THE BREAST TUMOR-ASSOCIATED ANTIGEN DEFINED BY MONOCLONAL ANTIBODY MBR1 AND USES THEREOF | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1996-10-31 | — | — | WO | disclosed |